Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Adverum Biotechnlgs (NQ: ADVM)
3.340 USD  +0.140 (+4.37%)
Official Closing Price  /  Updated: 4:34 PM EST, Jan 15, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 172,872
Open 3.210
Bid (Size) 3.250 (20)
Ask (Size) 4.200 (1)
Prev. Close 3.200
Today's Range 3.210 - 3.350
52wk Range 2.620 - 8.590
Shares Outstanding 62,271,901
Dividend Yield N/A
Performance
YTD
-2.05%
-2.05%
1 Month
-3.19%
-3.19%
3 Month
-33.86%
-33.86%
6 Month
-35.77%
-35.77%
1 Year
-23.22%
-23.22%
Top News
More News
Adverum Biotechnologies Provides 2019 Outlook
Advancing Novel Gene Therapy ADVM-022 for Wet AMD in OPTIC Phase 1 Clinical Trial Read More
from GlobeNewswire News Releases
Adverum to Present at the 37th Annual J.P. Morgan Healthcare Conference
Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ophthalmology and rare diseases, today announced the company will be participating... Read More
from GlobeNewswire News Releases
More News
Read More
Adverum Biotechnologies Appoints Mike Fitzgerald as Vice President, Human Resources
from GlobeNewswire News Releases
Adverum Biotechnologies Announces Publication of Preclinical Long-Term Expression and Efficacy Data in Molecular Therapy
from GlobeNewswire News Releases
Adverum Announces First Patient Dosed in OPTIC Phase 1 Trial of ADVM-022 Gene Therapy in Wet Age-Related Macular Degeneration
from GlobeNewswire News Releases
Adverum to Present at 30th Annual Piper Jaffray Healthcare Conference
from GlobeNewswire News Releases
Adverum Biotechnologies Reports Third Quarter 2018 Financial Results and Provides Corporate Update
from GlobeNewswire News Releases
Investor Expectations to Drive Momentum within Consolidated Edison, MUELLER WATER PRODUCTS, Adverum Biotechnologies, Buckeye Partners, inTest, and Live Nation Entertainment — Discovering Underlying Fa
from GlobeNewswire News Releases
Adverum Biotechnologies Stock Sees Short Interest Decline 16.2%
category Stocks
from Market News Video
We Did The Math KOMP Can Go To $37
category ETFs
from ETF Channel
Short Interest In Adverum Biotechnologies Drops 14.7%
category Stocks
from Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.